Colgate-Palmolive (CL) Sets New 1-Year High at $70.06

Colgate-Palmolive (NYSE:CL) hit a new 52-week high on Monday . The company traded as high as $70.06 and last traded at $69.45, with a volume of 192703 shares changing hands. The stock had previously closed at $69.35.

A number of equities research analysts have recently weighed in on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “sell” rating in a report on Monday, April 15th. Citigroup set a $68.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Tuesday, March 19th. UBS Group increased their target price on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, March 29th. Macquarie set a $57.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Tuesday, January 29th. Finally, Credit Suisse Group started coverage on shares of Colgate-Palmolive in a research report on Wednesday, March 6th. They issued an “underperform” rating on the stock. Three research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $65.73.

The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.76 and a current ratio of 1.14. The stock has a market cap of $59.63 billion, a P/E ratio of 23.24, a price-to-earnings-growth ratio of 4.55 and a beta of 0.79.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 25th. The company reported $0.74 EPS for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. The firm had revenue of $3.81 billion for the quarter, compared to the consensus estimate of $3.78 billion. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The company’s revenue was down 2.1% on a year-over-year basis. During the same period last year, the firm posted $0.75 EPS. As a group, analysts predict that Colgate-Palmolive will post 2.83 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.43 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 annualized dividend and a yield of 2.49%. The ex-dividend date is Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.

In other Colgate-Palmolive news, CEO Ian M. Cook sold 22,634 shares of the firm’s stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the transaction, the chief executive officer now directly owns 1,162,793 shares of the company’s stock, valued at approximately $77,104,803.83. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John T. Cahill sold 5,780 shares of the firm’s stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $64.46, for a total transaction of $372,578.80. Following the transaction, the director now directly owns 27,820 shares in the company, valued at $1,793,277.20. The disclosure for this sale can be found here. Insiders have sold a total of 103,200 shares of company stock worth $6,900,449 over the last three months. 1.14% of the stock is currently owned by insiders.

A number of institutional investors have recently modified their holdings of the business. Bristlecone Advisors LLC grew its position in Colgate-Palmolive by 2.6% during the 1st quarter. Bristlecone Advisors LLC now owns 23,402 shares of the company’s stock worth $1,604,000 after purchasing an additional 585 shares during the last quarter. Winthrop Advisory Group LLC purchased a new position in Colgate-Palmolive during the 1st quarter worth $233,000. Creative Financial Designs Inc. ADV purchased a new position in Colgate-Palmolive during the 1st quarter worth $157,000. Mercer Global Advisors Inc. ADV purchased a new position in Colgate-Palmolive during the 1st quarter worth $3,120,000. Finally, Lindbrook Capital LLC grew its position in Colgate-Palmolive by 32.8% during the 1st quarter. Lindbrook Capital LLC now owns 818 shares of the company’s stock worth $56,000 after purchasing an additional 202 shares during the last quarter. 76.27% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This story was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/04/24/colgate-palmolive-cl-sets-new-1-year-high-at-70-06.html.

About Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: Special Dividends

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.